Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at brentuximab for Hodgkin lymphoma (BREVITY)

Overview

Cancer types:

Blood cancers, Hodgkin lymphoma

Status:

Results

Phase:

Phase 2

Details

This trial was for older, frail people or those with other health conditions who couldn’t have chemotherapy.

Recruitment start: 1 February 2014

Recruitment end: 31 October 2015

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor John Radford

Supported by

Bloodwise

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

University of Birmingham

Last reviewed: 01 May 2018

CRUK internal database number: 9668

Help and support